Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN-MedSci.cn

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN

Bjorklund, CC; Kang, J; Amatangelo, M; Polonskaia, A; Katz, M; Chiu, H; Couto, S; Wang, M; Ren, Y; Ortiz, M; Towfic, F; Flynt, JE; Pierceall, W; Thakurta, A

Thakurta, A (corresponding author), Celgene Corp, Summit, NJ 07901 USA.

LEUKEMIA, 2020; 34 (4): 1197

科室
- - 订阅+
  - 更多科室
工具
服务